Evaluations of Biomarker Status Changes between Primary and Recurrent Tumor Tissue Samples in Breast Cancer Patients

BACKGROUND: Obtaining tumor specimens and re-evaluating targeted markers is recommended, if possible, in breast cancer patients who relapsed after curative treatment. The biomarker status changes in rebiopsied tumors have been demonstrated to have considerable clinical implications. OBJECTIVES: To i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi Hoa, Nguyen, Van Hung, Nguyen, Thanh Long, Qiuyin, Cai, Phung, Thi Huyen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754865/
https://www.ncbi.nlm.nih.gov/pubmed/31583246
http://dx.doi.org/10.1155/2019/7391237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754865/
https://www.ncbi.nlm.nih.gov/pubmed/31583246
http://dx.doi.org/10.1155/2019/7391237

Ejemplares similares